Study

You may benefit from

Vitamin EB1
Newsletter

54 patients with SIBO and IBS received S.Boulardii.

By OxidativeState · · 1 min read

PubMed: Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot Study

54 patients with SIBO and IBS received S.Boulardii.
The results?
-less diarrhea
-improved digestive symptoms
-reduced bacterial overgrowth

CNCM I-745 strand is effective in treating SIBO.

The study in brief

Does Saccharomyces boulardii help SIBO with IBS-D?

It may help a little. Breath hydrogen fell 41% with S. boulardii plus dietary advice against 29% with dietary advice alone, a difference the authors call slight.

Who was studied
54 patients with bacterial overgrowth and diarrhea-predominant irritable bowel syndrome, of whom 48 were evaluated.
What they did
A randomized, open-label pilot study gave S. boulardii CNCM I-745 plus dietary advice or dietary advice alone for 15 days. Overgrowth was measured with a lactulose hydrogen breath test.
What they found
The symptom severity score fell by 134 points with the yeast against 93 without it. Diarrhea was present in 25.9% of the yeast group against 47.6% without it.
What it does not show
Open-label pilot with no placebo, lasting 15 days. The abstract gives no P values for these comparisons.
Note on the post above
Not all 54 patients received the yeast: of the 48 evaluated, 27 took it with dietary advice and 21 had dietary advice alone.

Summary written from the PubMed abstract, not from the full paper.

The study

  1. Impact of Saccharomyces boulardii CNCM I-745 on Bacterial Overgrowth and Composition of Intestinal Microbiota in Diarrhea-Predominant Irritable Bowel Syndrome Patients: Results of a Randomized Pilot StudyDig Dis · 2023 · PMID 36630947
Read on X ↗

Get the next article in your inbox

Join the free newsletter. Science-backed health, no spam.